APTO-253 hydrochloride
CAS No. 1422731-37-0
APTO-253 hydrochloride( APTO253 | LOR253 | LOR-253 )
Catalog No. M11776 CAS No. 1422731-37-0
APTO-253 is a small molecule inducer of KLF4, stabilizes G-quadruplex DNA and reduces MYC mRNA expression and protein levels.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAPTO-253 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionAPTO-253 is a small molecule inducer of KLF4, stabilizes G-quadruplex DNA and reduces MYC mRNA expression and protein levels.
-
DescriptionAPTO-253 is a small molecule inducer of KLF4, stabilizes G-quadruplex DNA and reduces MYC mRNA expression and protein levels; APTO-253 is converted intracellularly from a monomer to a ferrous complex [Fe(253)3]; selectively induces CDKN1A (p21), promotes G0-G1 cell-cycle arrest, and triggers apoptosis in acute myeloid leukemia (AML) cells without producing myelosuppression in various animal species and humans, induces DNA Damage in AML cells.Blood Cancer Phase 1 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsAPTO253 | LOR253 | LOR-253
-
PathwayCell Cycle/DNA Damage
-
Targetc-Myc
-
Recptorc-Myc
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number1422731-37-0
-
Formula Weight403.845
-
Molecular FormulaC22H15ClFN5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=C(C2=C(N1)C=C(C=C2)F)C3=NC4=C5C=CC=NC5=C6C(=C4N3)C=CC=N6.Cl
-
Chemical Name2-(6-fluoro-2-methyl-1H-indol-3-yl)-1H-imidazo[4,5-f][1,10]phenanthroline hydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tsai CY, et al. Mol Cancer Ther. 2018 Apr 6. doi: 10.1158/1535-7163.MCT-17-0834.
2. Cercek A, et al. Invest New Drugs. 2015 Oct;33(5):1086-92.
3. Wang B, et al. Biochem Biophys Res Commun. 2017 Mar 11;484(3):486-492.
4. Local A, et al. Mol Cancer Ther. 2018 Apr 6. doi: 10.1158/1535-7163.MCT-17-1209.
molnova catalog
related products
-
IRES-C11
A novel, spectfic c-Myc IRES (internal ribosome entry site) function inhibitor that prevents binding of hnRNP A1 to the Myc IRES and specifically inhibits Myc IRES activity in MM cells.
-
NY2267
NY2267 is a disruptor of Myc-Max interaction, with an IC50 of 36.5 μM.
-
sAJM-589
sAJM-589 is a novel, potent small molecule Myc inhibitor that disrupts the Myc-Max leucine-zipper heterodimer with IC50 of 1.8 uM.
Cart
sales@molnova.com